The Block Trade on the Venture Exchange
A registered representative at a CIRO member firm receives an order from a client to buy 200,000 shares of a TSX Venture Exchange mining issuer at $0.85. The stock's average daily volume is 35,000 shares. The client is the spouse of a company director, and the issuer has a drilling-results news release scheduled within days. The client says, 'Use whatever price you need, just get it done before Friday,' and asks the rep not to mention the order to the branch manager. The firm's principal trading desk already holds 50,000 shares of the same issuer. The rep's KYC file shows the client has a $400,000 portfolio and moderate risk tolerance; this order would represent about 42% of the account. The rep wonders whether to accept the order, work it quietly, or escalate.
1. Identify the regulatory and ethical issues raised by the order. For each, explain how the specific facts affect whether the rep may accept or execute it.
Read the worked answer
1. Insider trading and tipping The client is the spouse of a director, and a drilling-results release is pending. That release is potentially material non-public information. The timing, relationship, urgency, and request for secrecy are red flags even if the client never says she has inside information. The rep must not execute, recommend, or pass along information while in possession of MNPI. The firm must inquire before acting.
2. Market manipulation and price impact The order is 200,000 shares against average daily volume of 35,000 shares, or about 5.7 days of normal volume. Aggressive execution could distort the price. Market-integrity rules prohibit manipulative or deceptive trading, and the firm still owes best execution and client-priority obligations. The rep cannot simply 'get it done' without regard to price impact.
3. Conflict of interest The firm's principal desk holds 50,000 shares. The firm could be a counterparty or could be tempted to trade ahead of the client order. That conflict must be identified, escalated, and managed; the rep cannot allow the desk to front-run the client.
4. Suitability and concentration The order is about $170,000, or roughly 42% of a $400,000 account with moderate risk tolerance. That is a large, illiquid concentration. The rep needs a suitability review and a clear client acknowledgment of liquidity and concentration risk.
5. Secrecy request The rep cannot agree to withhold the order from the branch manager. Escalation is required. The correct immediate step is not to execute, but to document the facts and escalate to compliance.
2. Assume compliance is contacted. Outline the steps the firm should take before any execution, including order-handling and documentation.
Read the worked answer
- Do not execute the order yet. Place it on hold and preserve all records, including the call notes and the client's instructions.
- Escalate to compliance and the branch manager. The secrecy request itself should be documented as a red flag.
- Inquire into the source of the information. Ask the client, without disclosing anything, how she learned of the timing and why she wants execution before Friday. Do not reveal the firm's concerns in a way that could amount to tipping.
- Check restricted lists and the director relationship. Confirm whether the issuer or director is on the firm's restricted list and whether the client is an insider or a tippee.
- Involve legal counsel if there is a credible suspicion of MNPI. The firm may need to decline the order and consider regulatory reporting.
- Separate the principal desk. Instruct the desk not to trade in the issuer while the client order is under review.
- Revisit suitability. Update the KYC discussion for concentration, liquidity, and the client's ability to bear a loss. Document the client's rationale and any written acknowledgment.
- Record the decision. Document who approved or rejected the order, what was considered, and why. If the order is declined, communicate the reason to the client in a compliant way.
3. If compliance later clears the order, what execution approach and client disclosures are appropriate given the thin market and the pending news?
Read the worked answer
Execution should be patient and transparent:
- Use limit orders and a VWAP or TWAP schedule over several days rather than a single aggressive sweep. Keep participation to a reasonable share of volume, for example 10% to 15% of average daily volume, unless the client accepts greater price impact.
- Avoid trading immediately before the pending news release if there is any remaining question about MNPI. If compliance has cleared the order because the information is not MNPI, document that conclusion.
- Do not cross with the firm's principal inventory unless the client consents after disclosure and the price is fair and documented. Best execution must be shown across venues.
- Tell the client that the order cannot be completed quickly without moving the price, that execution may take several days, and that the final average price may differ from $0.85.
- Obtain written acknowledgment of the concentration, illiquidity, and price-impact risk. Update the KYC file.
- Document the execution rationale, the venue choices, and any deviation from the plan. If the client insists on immediate execution, explain why the firm cannot accept that instruction in this market.